UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$235M |
| 2 |
Microsoft
MSFT
|
+$176M |
| 3 |
Cognizant
CTSH
|
+$150M |
| 4 |
Chubb
CB
|
+$107M |
| 5 |
Under Armour
UAA
|
+$100M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$221M |
| 2 |
Workday
WDAY
|
+$133M |
| 3 |
Pfizer
PFE
|
+$122M |
| 4 |
Apple
AAPL
|
+$122M |
| 5 |
Nike
NKE
|
+$116M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.48% |
| 2 | Technology | 14.7% |
| 3 | Financials | 13.4% |
| 4 | Consumer Discretionary | 10.5% |
| 5 | Communication Services | 9.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KND
1576
DELISTED
Kindred Healthcare
KND
| $1M | ﹤0.01% |
81,125
-9,051
| -10% | -$93.8K |
|
|
PINC
1577
DELISTED
Premier
PINC
| $1M | ﹤0.01% |
29,973
-1,705
| -5% | -$55.5K |
|
|
TPH
1578
DELISTED
Tri Pointe Homes
TPH
| $998K | ﹤0.01% |
84,752
-22,915
| -21% | -$242K |
|
|
SCTY
1579
DELISTED
SolarCity Corporation
SCTY
| $998K | ﹤0.01% |
40,571
-11,802
| -23% | -$337K |
|
1580
Mueller Industries
MLI
$15.2B
| $994K | ﹤0.01% |
135,184
+22,792
| +20% | +$150K |
|
1581
Novavax
NVAX
$1.31B
| $993K | ﹤0.01% |
9,630
-885
| -8% | -$94.9K |
|
1582
Precigen
PGEN
$2.59B
| $992K | ﹤0.01% |
29,523
-8,254
| -22% | -$260K |
|
1583
MillerKnoll
MLKN
$1.67B
| $989K | ﹤0.01% |
32,046
-5,052
| -14% | -$134K |
|
1584
ASE Group
ASX
$82.2B
| $986K | ﹤0.01% |
168,555
-157
| -0.1% | -$855 |
|
|
ALX
1585
Alexander's
ALX
$1.41B
| $983K | ﹤0.01% |
2,584
-1,634
| -39% | -$619K |
|
1586
Element Solutions
ESI
$9.23B
| $981K | ﹤0.01% |
114,116
-18,869
| -14% | -$149K |
|
|
GK
1587
DELISTED
G&K Services Inc
GK
| $978K | ﹤0.01% |
13,346
+1,988
| +18% | +$130K |
|
1588
Cal-Maine
CALM
$3.99B
| $977K | ﹤0.01% |
18,834
-5,519
| -23% | -$275K |
|
1589
New York Times
NYT
$10.2B
| $972K | ﹤0.01% |
78,029
-16,634
| -18% | -$211K |
|
1590
Rambus
RMBS
$11B
| $971K | ﹤0.01% |
70,589
-14,637
| -17% | -$181K |
|
|
FOMX
1591
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $971K | ﹤0.01% |
148,891
+50,333
| +51% | +$325K |
|
|
RSE
1592
DELISTED
ROUSE PPTYS INC COM (DE)
RSE
| $971K | ﹤0.01% |
52,823
-33,460
| -39% | -$577K |
|
|
GCP
1593
DELISTED
GCP Applied Technologies Inc.
GCP
| $970K | ﹤0.01% |
+48,655
| New | +$884K |
|
|
SONC
1594
DELISTED
Sonic Corp
SONC
| $963K | ﹤0.01% |
27,398
-13,900
| -34% | -$415K |
|
1595
Horace Mann Educators
HMN
$2.11B
| $962K | ﹤0.01% |
30,357
-7,582
| -20% | -$233K |
|
|
WMGI
1596
DELISTED
Wright Medical Group Inc
WMGI
| $962K | ﹤0.01% |
57,954
-18,967
| -25% | -$352K |
|
|
CDR
1597
DELISTED
Cedar Realty Trust, Inc
CDR
| $961K | ﹤0.01% |
20,132
-7,378
| -27% | -$339K |
|
1598
Plexus
PLXS
$7.23B
| $957K | ﹤0.01% |
24,214
-1,618
| -6% | -$57.3K |
|
1599
Churchill Downs
CHDN
$6.12B
| $956K | ﹤0.01% |
38,796
-1,800
| -4% | -$41.1K |
|
|
MEG
1600
DELISTED
Media General, Inc
MEG
| $956K | ﹤0.01% |
58,601
-12,152
| -17% | -$196K |
|
Similar funds
UBS AM's Q1 2016 Portfolio in Review
As of Q1 2016, UBS AM held 2,740 positions worth $86.2B, down 1.7% from $87.7B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
UBS AM's Q1 2016 filing shows 51 new, 583 increased, 1,774 reduced and 113 closed positions. Its largest new stake was NXP Semiconductors: 1,291,575 shares worth $105M. The largest sale was Thermo Fisher Scientific, an estimated $221M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 17% a quarter earlier, followed by Technology and Financials.
- UBS AM's largest Q1 2016 buy was NXP Semiconductors: 1,291,575 shares worth $105M.
- UBS AM added most to Alibaba in Q1 2016, an estimated $235M increase.
- UBS AM's biggest Q1 2016 reduction was Thermo Fisher Scientific, cutting an estimated $221M.
- UBS AM fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $97.5M.
- UBS AM's ten largest holdings make up 15% of its $86.2B portfolio in Q1 2016.
- UBS AM opened 51 new positions and closed 113 in Q1 2016.
- UBS AM's portfolio value fell 1.7% quarter-over-quarter to $86.2B.
Based on UBS AM's 13F filing for Q1 2016, filed 12 May 2016.